Tag: oral immunotherapy (OIT)

AAFA Press Release Regarding ICER Review

Asthma and Allergy Foundation of America Elevates Patient Voice in ICER...

Affirms Burden of Food Allergies on Families, Patients, and Caregivers.
FARE-ACAAI-AAN Statement

Joint Statement on Peanut Allergy Therapy Review

Organizations representing patients and allergists urge ICER to adopt a more patient-driven approach to assessing immunotherapies for peanut allergy.
AR101

Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101...

“Results of the European ARTEMIS trial provide further clinical validation of the safety and efficacy of AR101 for children and adolescents with peanut allergy.”
AR101

Aimmune Announces US FDA Advisory Committee Meeting Date for AR101 for...

The FDA will review Aimmune's Biologics Licence Application for AR101 on September 13, 2019.
OIT

Leading Allergists, Researchers and Food Allergy Advocates to Discuss State of...

The summit intends to address the risks and benefits of OIT, OIT implementation in practice and the gaps in knowledge about OIT to enable physicians to have a better understanding of this therapy and to help patients make fully-informed choices about treatment options.
Infighting

OIT is a Therapy, Not an Ideology

The decisions we all face as patients and caretakers depend on the individual, their allergies, their lifestyles and myriad other factors.
Peanuts

Study: Peanut OIT Increases Allergic Reactions, Compared with Avoidance or Placebo

Despite effectively inducing desensitisation in the clinic, OIT for peanut allergies appears to considerably increase allergic and anaphylactic reactions, compared with avoidance or placebo.
UBC OIT

Study: OIT Safe for Preschool-Aged Children with Peanut Allergies

"Our findings confirm in a real-world setting that this treatment is not only safe but is well-tolerated in a large group of preschool-aged children."
Giorgi Sisters

Must See: ‘ViewFinder: Food for Thought – Food Allergies’

This documentary should be required viewing for everyone as the food allergy epidemic has affected so many in the community.
AR101

European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary...

Company Intends to Submit European MAA in Mid-2019.

Connect with Us

38,125FansLike
578FollowersFollow
2,655FollowersFollow
5,439FollowersFollow
38SubscribersSubscribe